Host serine proteases: a potential targeted therapy for COVID-19 and influenza

Y Rahbar Saadat, SM Hosseiniyan Khatibi… - Frontiers in Molecular …, 2021 - frontiersin.org
The ongoing pandemic illustrates limited therapeutic options for controlling SARS-CoV-2
infections, calling a need for additional therapeutic targets. The viral spike S glycoprotein …

Therapeutic effectiveness and safety of repurposing drugs for the treatment of COVID-19: position standing in 2021

S Alam, TB Kamal, MMR Sarker, JR Zhou… - Frontiers in …, 2021 - frontiersin.org
COVID-19, transmitted by SARS-CoV-2, is one of the most serious pandemic situations in
the history of mankind, and has already infected a huge population across the globe. This …

Interrelationship between COVID-19 and coagulopathy: pathophysiological and clinical evidence

B Ragnoli, B Da Re, A Galantino, S Kette… - International Journal of …, 2023 - mdpi.com
Since the first description of COVID-19 infection, among clinical manifestations of the
disease, including fever, dyspnea, cough, and fatigue, it was observed a high incidence of …

Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer

M Sharma, AK Bakshi, N Mittapelly, S Gautam… - Journal of Controlled …, 2022 - Elsevier
The multi-dimensional challenge of drug resistance is one of the pivotal hindrances for
cancer chemotherapy. A reductive approach to define and distinguish the main aspects of …

Correlation between hepatocyte growth factor (HGF) with D-dimer and interleukin-6 as prognostic markers of coagulation and inflammation in long COVID-19 …

B Zaira, T Yulianti, J Levita - Current Issues in Molecular Biology, 2023 - mdpi.com
In general, an individual who experiences the symptoms of Severe Acute Respiratory
Syndrome Coronavirus 2 or SARS-CoV-2 infection is declared as recovered after 2 weeks …

[HTML][HTML] Multi-targeted molecular docking, pharmacokinetics, and drug-likeness evaluation of coumarin based compounds targeting proteins involved in development …

CS Mun, LY Hui, LC Sing, R Karunakaran… - Saudi journal of …, 2022 - Elsevier
COVID-19 is a progressing pandemic of coronavirus disease-2019, which had drowned the
whole world in a deep sorrow sea. Uncountable deaths were extending the list of deaths …

Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach

FA Ambrosio, G Costa, I Romeo… - Journal of Chemical …, 2023 - ACS Publications
The SARS-CoV-2 main protease (Mpro) is a crucial enzyme for viral replication and has
been considered an attractive drug target for the treatment of COVID-19. In this study, virtual …

Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection

W Dong, J Wang, L Tian, J Zhang, EW Settles… - Nature …, 2023 - nature.com
Serine proteases (SP), including furin, trypsin, and TMPRSS2 cleave the SARS-CoV-2 spike
(S) protein, enabling the virus to enter cells. Here, we show that factor (F) Xa, an SP involved …

Races of small molecule clinical trials for the treatment of COVID‐19: an up‐to‐date comprehensive review

S Hu, S Jiang, X Qi, R Bai, XY Ye… - Drug Development …, 2022 - Wiley Online Library
Abstract The coronavirus disease‐19 (COVID‐19) pandemic has become a global threat
since its first outbreak at the end of 2019. Several review articles have been published …

Parallel imaging of coagulation pathway proteases activated protein C, thrombin, and factor Xa in human plasma

S Modrzycka, S Kołt, SGI Polderdijk, TE Adams… - Chemical …, 2022 - pubs.rsc.org
Activated protein C (APC), thrombin, and factor (f) Xa are vitamin K-dependent serine
proteases that are key factors in blood coagulation. Moreover, they play important roles in …